Michael Smith. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/economicsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/economicsAntineoplastic Agents/therapeutic useBreast Neoplasms/drug therapyBreast Neoplasms/economicsBreast Neoplasms/mortalityBreast Neoplasms/pathologyCanada/epidemiologyDisease-Free SurvivalDrug Approval/economicsDrug CostsFemaleHumansNeoplasm InvasivenessPublic OpinionRandomized Controlled Trials as TopicSurvival AnalysisTrastuzumab
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsTrastuzumab
Year: 2005 PMID: 16174852 DOI: 10.1093/jnci/dji327
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506